Atlas Trials

14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection

Clinical trial NCT05438550 · UNKNOWN

Trial details

NCT number
NCT05438550
Sponsor
Shandong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2023-02-14
Primary completion
2023-12-20
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.